Unibail-Rodamco-Westfield SE (LON:0YO9)
91.58
+0.92 (1.02%)
At close: Dec 12, 2025
LON:0YO9 Revenue
Unibail-Rodamco-Westfield SE had revenue of 1.85B EUR in the half year ending June 30, 2025, with 27.95% growth. This brings the company's revenue in the last twelve months to 3.61B, up 21.61% year-over-year. In the year 2024, Unibail-Rodamco-Westfield SE had annual revenue of 3.29B with 13.84% growth.
Revenue (ttm)
3.61B EUR
Revenue Growth
+21.61%
P/S Ratio
3.74
Revenue / Employee
1.50M EUR
Employees
2,410
Market Cap
11.57B GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.29B | 400.30M | 13.84% |
| Dec 31, 2023 | 2.89B | -60.60M | -2.05% |
| Dec 31, 2022 | 2.95B | 1.00B | 51.45% |
| Dec 31, 2021 | 1.95B | 955.50M | 96.16% |
| Dec 31, 2020 | 993.70M | -2.31B | -69.92% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 200.18B |
| BP p.l.c. | 138.32B |
| Unilever | 51.24B |
| AstraZeneca | 43.24B |
| HSBC Holdings | 43.13B |
| Rio Tinto Group | 39.22B |
| GSK plc | 32.17B |
| Barclays | 26.02B |